UPDATE 1-Roche rheumatoid arthritis drug fails to help COVID-19 patients in Italian study

Roche's rheumatoid arthritis drug Actemra failed to help patients with early-stage COVID-19 pneumonia in an Italian study, researchers reported on Wednesday, but the Swiss drugmaker is testing the medicine in another trial against the illness caused by the new coronavirus.